Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam and remifentanil for awake fiberoptic intubation sedation
ChiCTR2100042917Phase 4Recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Jan 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, remifentanil and lidocaine in Not applicable (5 arms), sponsored by Beijing Friendship Hospital. Primary endpoints: Bispectral index, Modified Observers' Assessment of Alertness/Sedation scale and 7 more. Started Jan 2021; status: recruiting.
02
Drugs
remimazolamremifentanillidocaine
03
Conditions
Not applicable
Beyond the preview
Go deeper on ChiCTR2100042917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042917.